Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of FERVENT SYNERGIES. For more details, see the FERVENT SYNERGIES quarterly results and FERVENT SYNERGIES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 4.9 |
No. of shares | m | 30.00 |
1 Week | % | 1.4 |
1 Month | % | -19.7 |
1 Year | % | -5.1 |
52 week H/L | Rs | 27.8/15.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
FERVENT SYNERGIES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 32 | 28 | 19 | 27 | 22 | |
Low | Rs | 21 | 10 | 7 | 12 | 11 | |
Sales per share (Unadj.) | Rs | 5.6 | 2.5 | 0.7 | 0.3 | 1.5 | |
Earnings per share (Unadj.) | Rs | 0.4 | 0.1 | 0.1 | -0.1 | 0.1 | |
Diluted earnings per share | Rs | 0.4 | 0.1 | 0.1 | -0.1 | 0.1 | |
Cash flow per share (Unadj.) | Rs | 0.4 | 0.1 | 0.1 | -0.1 | 0.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 14.3 | 14.2 | 14.3 | 14.3 | 14.4 | |
Adj. book value per share | Rs | 14.3 | 14.2 | 14.3 | 14.3 | 14.4 | |
Shares outstanding (eoy) | m | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | |
Price / Sales ratio | x | 4.8 | 7.9 | 18.0 | 67.6 | 10.7 | |
Avg P/E ratio | x | 64.6 | 246.3 | 228.0 | -242.6 | 215.8 | |
P/CF ratio (eoy) | x | 64.0 | 223.1 | 188.5 | -287.7 | 183.8 | |
Price / Book Value ratio | x | 1.9 | 1.4 | 0.9 | 1.3 | 1.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 797 | 581 | 398 | 577 | 497 | |
Total wages/salary | Rs m | 2 | 2 | 2 | 3 | 3 |
FERVENT SYNERGIES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 167 | 74 | 22 | 9 | 46 | |
Other income | Rs m | 4 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 171 | 74 | 22 | 9 | 46 | |
Gross profit | Rs m | 14 | 5 | 3 | -2 | 5 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 1 | 1 | 0 | 0 | 0 | |
Profit before tax | Rs m | 17 | 3 | 2 | -2 | 4 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 5 | 1 | 1 | 0 | 2 | |
Profit after tax | Rs m | 12 | 2 | 2 | -2 | 2 | |
Gross profit margin | % | 8.4 | 6.2 | 12.5 | -20.9 | 10.3 | |
Effective tax rate | % | 28.9 | 23.4 | 25.5 | -20.0 | 47.3 | |
Net profit margin | % | 7.4 | 3.2 | 7.9 | -27.9 | 5.0 |
FERVENT SYNERGIES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 252 | 253 | 254 | 270 | 274 | |
Current liabilities | Rs m | 6 | 7 | 6 | 0 | 1 | |
Net working cap to sales | % | 147.2 | 334.6 | 1,122.3 | 3,163.9 | 588.7 | |
Current ratio | x | 39.8 | 35.1 | 43.6 | 772.1 | 205.9 | |
Inventory Days | Days | 392 | 866 | 2,930 | 2 | 0 | |
Debtors Days | Days | 66,167,696 | 131,408,893 | 2,889 | 0 | 470 | |
Net fixed assets | Rs m | 183 | 181 | 183 | 161 | 161 | |
Share capital | Rs m | 300 | 300 | 300 | 300 | 300 | |
"Free" reserves | Rs m | 128 | 126 | 130 | 130 | 132 | |
Net worth | Rs m | 428 | 426 | 430 | 430 | 432 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 435 | 434 | 437 | 431 | 435 | |
Interest coverage | x | 26.2 | 3.1 | 27.0 | -198.0 | 0 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.4 | 0.2 | 0.1 | 0 | 0.1 | |
Return on assets | % | 3.0 | 0.9 | 0.4 | -0.6 | 0.5 | |
Return on equity | % | 2.9 | 0.6 | 0.4 | -0.6 | 0.5 | |
Return on capital | % | 4.2 | 1.1 | 0.6 | -0.5 | 1.0 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 78.2 | 98.6 | 0 | 0 | 64.7 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 130 | 73 | 0 | 0 | 30 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 131 | 73 | 0 | 0 | 30 | |
Net fx | Rs m | -131 | -73 | -0 | -0 | -30 |
FERVENT SYNERGIES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 116 | 19 | 2 | -22 | -1 | |
From Investments | Rs m | -140 | -2 | -0 | 24 | -0 | |
From Financial Activity | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net Cashflow | Rs m | -25 | 17 | 2 | 2 | -1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Vijay Thakkar | COMP SEC: Nehal Bharat Mehta | YEAR OF INC: 2009 | BSE CODE: 533896 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare FERVENT SYNERGIES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.